Marker Therapeutics Inc - fluxo de caixa (NASDAQ:MRKR) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -18.86 M-27.28 M-26.97 M-16.44 M-10.91 M-12.01 M -12.01 M Cash from investing activities -10.43 M-3.13 M-4.95 M18.66 M18.66 M— — Cash from financing activities 6.74 M52.56 M202.13 K1.11 M14.99 M9.86 M 9.86 M Free cash flow -25.65 M-27.28 M-26.97 M-16.44 M-10.91 M-12.01 M -12.01 M

Notícias

H.C. Wainwright reitera classificação de compra para ação da Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

Marker Therapeutics define data para assembleia anual de acionistas de 2026 e prazo para propostas

Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?

5 Small Drug Stocks to Buy as Industry Recovery Picks Up

Marker Therapeutics mantém classificação de Compra pela H.C. Wainwright

Marker Therapeutics stock maintains Buy rating at H.C. Wainwright

Brookline Capital eleva preço-alvo das ações da Marker Therapeutics para US$ 5,60